1. Home
  2. VERB vs SNPX Comparison

VERB vs SNPX Comparison

Compare VERB & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERB
  • SNPX
  • Stock Information
  • Founded
  • VERB 2014
  • SNPX 2012
  • Country
  • VERB United States
  • SNPX United States
  • Employees
  • VERB N/A
  • SNPX N/A
  • Industry
  • VERB Other Consumer Services
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • VERB Consumer Discretionary
  • SNPX Health Care
  • Exchange
  • VERB Nasdaq
  • SNPX Nasdaq
  • Market Cap
  • VERB 4.7M
  • SNPX 4.1M
  • IPO Year
  • VERB N/A
  • SNPX N/A
  • Fundamental
  • Price
  • VERB $6.50
  • SNPX $2.40
  • Analyst Decision
  • VERB Strong Buy
  • SNPX Strong Buy
  • Analyst Count
  • VERB 1
  • SNPX 1
  • Target Price
  • VERB $100.00
  • SNPX $14.00
  • AVG Volume (30 Days)
  • VERB 176.1K
  • SNPX 18.6K
  • Earning Date
  • VERB 11-05-2024
  • SNPX 11-12-2024
  • Dividend Yield
  • VERB N/A
  • SNPX N/A
  • EPS Growth
  • VERB N/A
  • SNPX N/A
  • EPS
  • VERB N/A
  • SNPX N/A
  • Revenue
  • VERB $201,000.00
  • SNPX N/A
  • Revenue This Year
  • VERB $547.62
  • SNPX N/A
  • Revenue Next Year
  • VERB $300.00
  • SNPX N/A
  • P/E Ratio
  • VERB N/A
  • SNPX N/A
  • Revenue Growth
  • VERB 415.38
  • SNPX N/A
  • 52 Week Low
  • VERB $5.05
  • SNPX $2.32
  • 52 Week High
  • VERB $184.60
  • SNPX $8.78
  • Technical
  • Relative Strength Index (RSI)
  • VERB 33.15
  • SNPX 33.10
  • Support Level
  • VERB $9.08
  • SNPX $2.88
  • Resistance Level
  • VERB $10.20
  • SNPX $3.20
  • Average True Range (ATR)
  • VERB 1.33
  • SNPX 0.19
  • MACD
  • VERB -0.43
  • SNPX -0.06
  • Stochastic Oscillator
  • VERB 1.11
  • SNPX 8.88

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: